Evidence map›Paper›PMID 40757772›Full record

ArticleComprehensive physiology2025

Bile Acid Profile Differs Between Brain Regions in Rodents and Is Disrupted in a Rodent Model of Alzheimer's Disease.

Melanie A Reuter, Rosalinda Moreno, Madelynn E Agabao-Tucker, Rahaf Shishani, Jessica Miranda Bustamante, Zara Marfori, Taylor Richieri, Anthony E Valenzuela, Ameer Y Taha, Pamela J Lein and 2 more

Abstract read
In one paragraph

Article in Comprehensive physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Melanie A ReuterDepartment of Surgery, Center for Alimentary and Metabolic Science, School of Medicine, University of California-Davis, Sacramento, California, USA.ORCID 0000-0003-0888-4202
Rosalinda MorenoDepartment of Surgery, Center for Alimentary and Metabolic Science, School of Medicine, University of California-Davis, Sacramento, California, USA.
Madelynn E Agabao-TuckerDepartment of Surgery, Center for Alimentary and Metabolic Science, School of Medicine, University of California-Davis, Sacramento, California, USA.ORCID 0009-0008-0991-1202
Rahaf ShishaniDepartment of Surgery, Center for Alimentary and Metabolic Science, School of Medicine, University of California-Davis, Sacramento, California, USA.ORCID 0000-0003-0627-0151
Jessica Miranda BustamanteDepartment of Surgery, Center for Alimentary and Metabolic Science, School of Medicine, University of California-Davis, Sacramento, California, USA.
Zara MarforiDepartment of Surgery, Center for Alimentary and Metabolic Science, School of Medicine, University of California-Davis, Sacramento, California, USA.
Taylor RichieriDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
Anthony E ValenzuelaDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
Ameer Y TahaDepartment of Food Science and Technology, College of Agriculture and Environmental Sciences, University of California-Davis, Davis, California, USA.ORCID 0000-0003-4611-7450
Pamela J LeinDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.ORCID 0000-0001-7665-7584
Renu NandakumarBiomarkers Core Laboratory, Irving Institute for Clinical and Translational Research, Columbia University Irving Medical Center, New York, New York, USA.
Bethany P CummingsDepartment of Surgery, Center for Alimentary and Metabolic Science, School of Medicine, University of California-Davis, Sacramento, California, USA.ORCID 0000-0002-0610-9870

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
UC Davis Environmental Health Sciences Core CenterP30ES023513 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Irva Hertz-Picciotto · 2015 to 2026
$26.0M
UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Charles DeCarli, Rachel A Whitmer · 2021 to 2026
$25.2M
ENVIRONMENTAL TOXICOLOGYT32ES007059 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura S Van Winkle · 1985 to 2026
$7.9M
Initiative for Maximizing Student Development at the University of California, Davis.T32GM135741 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI ALDRIN V. GOMES, Manuel F Navedo · 2020 to 2026
$3.2M
Traffic-related air pollution exacerbates AD-relevant phenotypes in a genetically susceptible rat model via neuroinflammatory mechanism(s)RF1AG074709 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BEIN, KEITH, LEIN, PAMELA J · 2021 to 2021
$2.3M
Training Program in PharmacologyT32GM144303 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Donald M Bers, JOHANNES W HELL · 2022 to 2026
$2.1M
Mapping bile acid metabolism across the gut microbiome in response to dietary fiberR21AT010956 · NCCIH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CUMMINGS, BETHANY PAIGE · 2021 to 2022
$572k
NCATS NIH HHS UL1 TR001873NCCIH NIH HHS R21 AT010956NIA NIH HHS P30 AG072972NIA NIH HHS RF1 AG074709NIEHS NIH HHS P30 ES023513NIEHS NIH HHS T32 ES007059NIGMS NIH HHS T32 GM135741NIGMS NIH HHS T32 GM144303NIH HHS P30AG072972NIH HHS R21AT010956NIH HHS R21AT010956-02S1NIH HHS RF1AG074709NIH HHS T32ES007059NIH HHS T32GM135741NIH HHS T32GM144303NIH HHS UL1TR001873
6 · The paper itself

Abstract

Low but biologically relevant levels of bile acids are found in the brain and are altered in patients with Alzheimer's disease (AD). However, the regulation of brain bile acid levels and what drives brain bile acid dynamics are poorly understood. Bile acids are synthesized in the liver and further metabolized by bacteria in the gut. Therefore, bile acids are mediators of the liver-brain axis and the gut-brain axis. Additionally, whether the bile acid profile differs between brain regions and whether the brain region-specific bile acid profile is impacted by disease, such as AD, is unknown. Therefore, we tested the hypothesis that the brain bile acid profile is influenced by peripheral bile acid metabolism, differs between brain regions, and that these dynamics change in AD. To this end, we assessed the bile acid profile in the cortex and hippocampus of wild-type mice maintained on different diets. To test the effect of AD, we used the TgF344-AD rat model. We found that the brain bile acid profile in mice was mildly altered by diet and, in both mice and rats, differs substantially between brain regions. For example, cholic acid and taurocholic acid are enriched in the cortex relative to the hippocampus in both mice and rats. Further, using a rat model of AD, we found that brain region differences in bile acid profiles are attenuated in AD. Together, these data demonstrate that both peripheral and central regulatory mechanisms maintain bile acid homeostasis in specific brain regions and that these homeostatic mechanisms are disrupted in AD.

Indexed as

Alzheimer DiseaseBile Acids and SaltsBrainAnimalsDisease Models, AnimalHippocampusMaleMiceMice, Inbred C57BLRatsRats, Inbred F344Bile Acids and SaltsAlzheimer's diseasebile acidsgut–brain axisliver–brain axisresistant starch

Identifiers

PMID40757772
PMCPMC12320573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.